Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

KALA Insider Trading

KALA BIO, Inc. | Pharmaceutical Preparations

Comprehensive Trading Performance Summary

The investment history of corporate insiders at KALA BIO, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Pharmaceutical Preparations sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2025-10-25 03:00 2025-10-22 Kharabi Darius Officer - CHIEF BUSINESS OFFICER SELL $0.83 20,806 $17,269 41,760 -33.3%
2025-10-25 03:00 2025-10-22 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $0.83 33,197 $27,544 28,906 -53.5%
2025-10-25 03:00 2025-10-22 Bazemore Todd Director SELL $0.83 47,768 $39,647 35,932 -57.1%
2025-10-25 03:00 2025-10-23 Iwicki Mark T Director SELL $0.81 154,894 $125,464 103,540 -59.9%
2025-10-25 03:00 2025-10-22 Brazzell Romulus K Officer - SEE REMARKS SELL $0.83 46,748 $38,801 35,952 -56.5%
2025-10-02 23:47 2025-09-30 BAKER BROS. ADVISORS LP Other SELL $1.45 730,408 $1,056,754 425,006 -63.2%
2025-06-27 03:00 2025-06-24 Kharabi Darius Officer - CHIEF BUSINESS OFFICER SELL $4.01 4,511 $18,089 62,566 -6.7%
2025-06-27 03:00 2025-06-24 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $4.01 3,631 $14,560 62,100 -5.5%
2025-06-27 03:00 2025-06-24 Bazemore Todd Officer - SEE REMARKS SELL $4.01 4,058 $16,273 83,699 -4.6%
2025-06-27 03:00 2025-06-24 Iwicki Mark T Director SELL $4.01 13,227 $53,040 258,433 -4.9%
2025-06-27 03:00 2025-06-24 Brazzell Romulus K Officer - SEE REMARKS SELL $4.01 5,251 $21,057 82,698 -6.0%
2025-06-05 03:00 2025-06-03 Kharabi Darius Officer - CHIEF BUSINESS OFFICER SELL $3.74 730 $2,730 67,077 -1.1%
2025-06-05 03:00 2025-06-03 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $3.74 2,850 $10,659 65,731 -4.2%
2025-06-05 03:00 2025-06-03 Bazemore Todd Officer - SEE REMARKS SELL $3.74 3,390 $12,679 87,757 -3.7%
2025-06-05 03:00 2025-06-03 Iwicki Mark T Director SELL $3.74 10,866 $40,639 269,210 -3.9%
2025-06-05 03:00 2025-06-03 Brazzell Romulus K Officer - SEE REMARKS SELL $3.74 3,687 $13,789 87,949 -4.0%
2025-01-08 04:14 2025-01-06 Kharabi Darius Officer - CHIEF BUSINESS OFFICER SELL $7.63 2,021 $15,420 67,807 -2.9%
2025-01-08 04:14 2025-01-06 Bazemore Todd Officer - SEE REMARKS SELL $7.63 1,993 $15,207 0 -100.0%
2025-01-08 04:12 2025-01-06 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $7.63 1,706 $13,017 68,581 -2.4%
2025-01-08 04:12 2025-01-06 Iwicki Mark T Director, Officer - CHIEF EXECUTIVE OFFICER SELL $7.63 5,779 $44,094 280,076 -2.0%
2025-01-08 04:13 2025-01-06 Brazzell Romulus K Officer - SEE REMARKS SELL $7.63 2,446 $18,663 92,418 -2.6%
2025-01-01 00:00 2024-12-30 BAKER BROS. ADVISORS LP 10% owner BUY $6.44 310,559 $2,000,000 1,083,398 +40.2%
2024-06-28 03:00 2024-06-26 Bazemore Todd Officer - SEE REMARKS SELL $4.75 4,653 $22,102 83,040 -5.3%
2024-06-28 03:00 2024-06-26 Kharabi Darius Officer - CHIEF BUSINESS OFFICER SELL $4.75 5,158 $24,501 59,728 -7.9%
2024-06-28 03:00 2024-06-26 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $4.75 4,163 $19,774 60,187 -6.5%
2024-06-28 03:00 2024-06-26 Iwicki Mark T Director, Officer - CHIEF EXECUTIVE OFFICER SELL $4.75 15,168 $72,048 263,755 -5.4%
2024-06-28 03:00 2024-06-26 Brazzell Romulus K Officer - SEE REMARKS SELL $4.75 5,489 $26,073 83,982 -6.1%
2024-06-04 03:00 2024-05-31 Bazemore Todd Officer - SEE REMARKS SELL $6.09 2,093 $12,746 87,693 -2.3%
2024-06-04 03:00 2024-05-31 Kharabi Darius Officer - CHIEF BUSINESS OFFICER SELL $6.09 231 $1,407 64,886 -0.4%
2024-06-04 03:00 2024-05-31 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $6.09 1,786 $10,877 64,350 -2.7%
2024-06-04 03:00 2024-05-31 Iwicki Mark T Director, Officer - CHIEF EXECUTIVE OFFICER SELL $6.09 7,392 $45,017 278,923 -2.6%
2024-06-04 03:00 2024-05-31 Brazzell Romulus K Officer - SEE REMARKS SELL $6.09 2,002 $12,192 89,471 -2.2%
2024-01-06 00:07 2024-01-04 Trachtenberg Eric Officer - SEE REMARKS SELL $6.74 1,227 $8,270 68,066 -1.8%
2024-01-06 00:06 2024-01-04 Kharabi Darius Officer - CHIEF BUSINESS OFFICER SELL $6.73 1,385 $9,321 65,117 -2.1%
2024-01-06 00:04 2024-01-04 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $6.74 1,227 $8,270 66,136 -1.8%
2024-01-06 00:03 2024-01-04 Bazemore Todd Officer - SEE REMARKS SELL $6.74 1,405 $9,470 0 -100.0%
2024-01-06 00:04 2024-01-04 Iwicki Mark T Director, Officer - CHIEF EXECUTIVE OFFICER SELL $6.73 4,539 $30,547 286,315 -1.6%
2024-01-06 00:05 2024-01-04 Brazzell Romulus K Officer - SEE REMARKS SELL $6.74 1,617 $10,899 91,473 -1.7%
2023-01-07 04:00 2023-01-04 Trachtenberg Eric Officer - SEE REMARKS SELL $28.55 60 $1,713 11,495 -0.5%
2023-01-07 04:00 2023-01-04 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $28.54 60 $1,712 11,883 -0.5%
2023-01-07 04:00 2023-01-04 Bazemore Todd Officer - SEE REMARKS SELL $28.54 62 $1,769 14,835 -0.4%
2023-01-07 04:00 2023-01-04 Iwicki Mark T Director, Officer - CHIEF EXECUTIVE OFFICER SELL $28.54 198 $5,651 45,966 -0.4%
2023-01-07 04:00 2023-01-04 Brazzell Romulus K Officer - SEE REMARKS SELL $28.53 73 $2,083 18,536 -0.4%
2022-10-28 23:15 2022-10-26 Trachtenberg Eric Officer - SEE REMARKS SELL $6.52 194 $1,265 2,030 -8.7%
2022-10-28 23:15 2022-10-26 Bazemore Todd Officer - SEE REMARKS SELL $6.51 214 $1,393 2,097 -9.3%
2022-10-28 23:15 2022-10-26 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $6.51 194 $1,263 2,418 -7.4%
2022-10-28 23:15 2022-10-26 Iwicki Mark T Director, Officer - CHIEF EXECUTIVE OFFICER SELL $6.52 561 $3,658 4,464 -11.2%
2022-10-28 23:15 2022-10-26 Brazzell Romulus K Officer - SEE REMARKS SELL $6.51 261 $1,699 5,809 -4.3%
2022-06-30 03:12 2022-06-27 Trachtenberg Eric Officer - SEE REMARKS SELL $0.37 2,613 $967 111,203 -2.3%
2022-06-30 03:12 2022-06-27 Reumuth Mary Officer - CHIEF FINANCIAL OFFICER SELL $0.37 2,613 $967 130,595 -2.0%
SHOW ENTRIES

How to Interpret $KALA Trades

Not every insider transaction in KALA BIO, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $KALA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for KALA

Insider activity data for KALA BIO, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $KALA, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.